Development of Carvedilol-Loaded Albumin-Based Nanoparticles with Factorial Design to Optimize In Vitro and In Vivo Performance

• Ngā kaituhi matua: Mohamed S. Attia (Author), Mohamed F. Radwan (Author), Tarek S. Ibrahim (Author), Tarek M. Ibrahim (Author)
• Hōputu: Pukapuka
• I whakaputaina: MDPI AG, 2023-05-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Carvedilol, an anti-hypertensive medication commonly prescribed by healthcare providers, falls under the BCS class II category due to its low-solubility and high-permeability characteristics, resulting in limited dissolution and low absorption when taken orally. Herein, carvedilol was entrapped into...